---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-066130"
form_type: "8-K"
ticker: "HOTH"
cik: "0001711786"
company_name: "Hoth Therapeutics, Inc."
filed_at: "2024-08-07T23:59:59+00:00"
generated_at: "2026-05-31T11:49:31.687712+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Hoth Therapeutics shareholders re-elect board, ratify auditor, approve equity plan increase

## Summary
- All five incumbent directors re-elected; vote totals ranged from 637,415 to 700,399 for each.
- Ratification of WithumSmith+Brown as auditor passed with 1,763,403 votes for (79.1% of votes cast).
- Amendment to 2022 Omnibus Equity Plan approved to increase reserved shares from 591,317 to 1,091,317.
- Quorum of 2,230,078 shares represented at the meeting.

## SEC filing metadata
- accession: 0001213900-24-066130
- form_type: 8-K
- ticker: HOTH
- cik: 0001711786
- company_name: Hoth Therapeutics, Inc.
- filed_at: 2024-08-07T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1711786/000121390024066130/0001213900-24-066130-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1711786/000121390024066130/ea0210818-8k_hoththera.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-066130
- JSON: https://secwatch.observer/filing/0001213900-24-066130.json
- Plain text: https://secwatch.observer/filing/0001213900-24-066130.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.